We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$22.8B
AUM Growth
-$4.8M
Cap. Flow
+$69.6M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.53%
Holding
188
New
24
Increased
37
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$580M
2
ADSK icon
Autodesk
ADSK
+$544M
3
MCK icon
McKesson
MCK
+$342M
4
TMO icon
Thermo Fisher Scientific
TMO
+$288M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$275M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$508M
2
CRM icon
Salesforce
CRM
+$266M
3
NOW icon
ServiceNow
NOW
+$264M
4
SPGI icon
S&P Global
SPGI
+$246M
5
SHW icon
Sherwin-Williams
SHW
+$212M

Sector Composition

Rank Sector Weight
1 Healthcare 33.98%
2 Technology 14.71%
3 Financials 12.17%
4 Communication Services 7.05%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
126
Grifois
GRFS
$5.44B
$208K ﹤0.01%
28,000
– –
INSM icon
127
Insmed
INSM
$27.5B
$207K ﹤0.01%
3,000
– –
ONC
128
BeOne Medicines Ltd
ONC
$42.4B
$203K ﹤0.01%
1,100
– –
ALT icon
129
Altimmune
ALT
$605M
$199K ﹤0.01%
27,600
– –
ELAN icon
130
Elanco Animal Health
ELAN
$12B
$194K ﹤0.01%
16,000
– –
IOVA icon
131
Iovance Biotherapeutics
IOVA
$3.76B
$192K ﹤0.01%
26,000
– –
SLDPW icon
132
Solid Power Inc Warrant
SLDPW
$6.93M
$182K ﹤0.01%
405,316
– –
EVH icon
133
Evolent Health
EVH
$536M
$158K ﹤0.01%
14,000
-625,000
-98% -$11M
GERN icon
134
Geron
GERN
$977M
$152K ﹤0.01%
43,000
– –
FOLD
135
DELISTED
Amicus Therapeutics
FOLD
$151K ﹤0.01%
16,000
– –
OSCR icon
136
Oscar Health
OSCR
$9.89B
$148K ﹤0.01%
11,000
– –
ANNAW
137
AleAnna Inc Warrant
ANNAW
$7.3M
$139K ﹤0.01%
+990,000
New +$151K
COGT icon
138
Cogent Biosciences
COGT
$6.37B
$133K ﹤0.01%
17,000
– –
SNDX icon
139
Syndax Pharmaceuticals
SNDX
$1.75B
$132K ﹤0.01%
10,000
– –
NVAX icon
140
Novavax
NVAX
$1.47B
$129K ﹤0.01%
16,000
– –
ARDX icon
141
Ardelyx
ARDX
$1B
$117K ﹤0.01%
23,000
– –
CCCC icon
142
C4 Therapeutics
CCCC
$492M
$101K ﹤0.01%
28,000
– –
CGC
143
Canopy Growth
CGC
$472M
$82.2K ﹤0.01%
30,000
– –
IRWD icon
144
Ironwood Pharmaceuticals
IRWD
$709M
$57.6K ﹤0.01%
13,000
– –
ANNA
145
AleAnna Inc
ANNA
$116M
$48.7K ﹤0.01%
+78,400
New +$569K
GATEW
146
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$48.3K ﹤0.01%
1,485,000
– –
CITEW
147
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$47.3K ﹤0.01%
175,000
– –
NVNIW
148
Nvni Group Limited Warrants
NVNIW
$24.8K ﹤0.01%
375,000
– –
RVMDW icon
149
Revolution Medicines Inc Warrant
RVMDW
$130M
$19.4K ﹤0.01%
120,085
– –
AMGN icon
150
Amgen
AMGN
$238B
– –
-47,000
Closed -$15.1M
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2024 Portfolio in Review

As of Q4 2024, Thomas Steyer held 188 positions worth $22.8B, down 0.02% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Thomas Steyer's Q4 2024 filing shows 24 new, 37 increased, 34 reduced and 37 closed positions. Its largest new stake was Autodesk: 1,841,800 shares worth $544M. The largest sale was CATALENT, INC., an estimated $508M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q4 2024 buy was Autodesk: 1,841,800 shares worth $544M.
  • Thomas Steyer added most to Discover Financial Services in Q4 2024, an estimated $580M increase.
  • Thomas Steyer's biggest Q4 2024 reduction was Salesforce, cutting an estimated $266M.
  • Thomas Steyer fully exited CATALENT, INC. in Q4 2024, selling an estimated $508M.
  • Thomas Steyer's ten largest holdings make up 40% of its $22.8B portfolio in Q4 2024.
  • Thomas Steyer opened 24 new positions and closed 37 in Q4 2024.
  • Thomas Steyer's portfolio value fell 0.02% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.